Phage Display Libraries for Antibody Therapeutic Discovery and Development

Phage display technology has played a key role in the remarkable progress of discovering and optimizing antibodies for diverse applications, particularly antibody-based drugs. This technology was initially developed by George Smith in the mid-1980s and applied by John McCafferty and Gregory Winter t...

Full description

Bibliographic Details
Main Authors: Juan C. Almagro, Martha Pedraza-Escalona, Hugo Iván Arrieta, Sonia Mayra Pérez-Tapia
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/8/3/44
id doaj-8b9bc4af569f452a94b96b307ba691d5
record_format Article
spelling doaj-8b9bc4af569f452a94b96b307ba691d52020-11-25T02:52:34ZengMDPI AGAntibodies2073-44682019-08-01834410.3390/antib8030044antib8030044Phage Display Libraries for Antibody Therapeutic Discovery and DevelopmentJuan C. Almagro0Martha Pedraza-Escalona1Hugo Iván Arrieta2Sonia Mayra Pérez-Tapia3GlobalBio, Inc., 320, Cambridge, MA 02138, USACONACyT-UDIBI, ENCB, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Casco de Santo Tomas, Delegación Miguel Hidalgo, Ciudad de Mexico 11340, MexicoCONACyT-UDIBI, ENCB, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Casco de Santo Tomas, Delegación Miguel Hidalgo, Ciudad de Mexico 11340, MexicoCONACyT-UDIBI, ENCB, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Casco de Santo Tomas, Delegación Miguel Hidalgo, Ciudad de Mexico 11340, MexicoPhage display technology has played a key role in the remarkable progress of discovering and optimizing antibodies for diverse applications, particularly antibody-based drugs. This technology was initially developed by George Smith in the mid-1980s and applied by John McCafferty and Gregory Winter to antibody engineering at the beginning of 1990s. Here, we compare nine phage display antibody libraries published in the last decade, which represent the state of the art in the discovery and development of therapeutic antibodies using phage display. We first discuss the quality of the libraries and the diverse types of antibody repertoires used as substrates to build the libraries, i.e., naïve, synthetic, and semisynthetic. Second, we review the performance of the libraries in terms of the number of positive clones per panning, hit rate, affinity, and developability of the selected antibodies. Finally, we highlight current opportunities and challenges pertaining to phage display platforms and related display technologies.https://www.mdpi.com/2073-4468/8/3/44naive repertoiressynthetic repertoiresantibody library designdevelopabilityhit rateaffinity
collection DOAJ
language English
format Article
sources DOAJ
author Juan C. Almagro
Martha Pedraza-Escalona
Hugo Iván Arrieta
Sonia Mayra Pérez-Tapia
spellingShingle Juan C. Almagro
Martha Pedraza-Escalona
Hugo Iván Arrieta
Sonia Mayra Pérez-Tapia
Phage Display Libraries for Antibody Therapeutic Discovery and Development
Antibodies
naive repertoires
synthetic repertoires
antibody library design
developability
hit rate
affinity
author_facet Juan C. Almagro
Martha Pedraza-Escalona
Hugo Iván Arrieta
Sonia Mayra Pérez-Tapia
author_sort Juan C. Almagro
title Phage Display Libraries for Antibody Therapeutic Discovery and Development
title_short Phage Display Libraries for Antibody Therapeutic Discovery and Development
title_full Phage Display Libraries for Antibody Therapeutic Discovery and Development
title_fullStr Phage Display Libraries for Antibody Therapeutic Discovery and Development
title_full_unstemmed Phage Display Libraries for Antibody Therapeutic Discovery and Development
title_sort phage display libraries for antibody therapeutic discovery and development
publisher MDPI AG
series Antibodies
issn 2073-4468
publishDate 2019-08-01
description Phage display technology has played a key role in the remarkable progress of discovering and optimizing antibodies for diverse applications, particularly antibody-based drugs. This technology was initially developed by George Smith in the mid-1980s and applied by John McCafferty and Gregory Winter to antibody engineering at the beginning of 1990s. Here, we compare nine phage display antibody libraries published in the last decade, which represent the state of the art in the discovery and development of therapeutic antibodies using phage display. We first discuss the quality of the libraries and the diverse types of antibody repertoires used as substrates to build the libraries, i.e., naïve, synthetic, and semisynthetic. Second, we review the performance of the libraries in terms of the number of positive clones per panning, hit rate, affinity, and developability of the selected antibodies. Finally, we highlight current opportunities and challenges pertaining to phage display platforms and related display technologies.
topic naive repertoires
synthetic repertoires
antibody library design
developability
hit rate
affinity
url https://www.mdpi.com/2073-4468/8/3/44
work_keys_str_mv AT juancalmagro phagedisplaylibrariesforantibodytherapeuticdiscoveryanddevelopment
AT marthapedrazaescalona phagedisplaylibrariesforantibodytherapeuticdiscoveryanddevelopment
AT hugoivanarrieta phagedisplaylibrariesforantibodytherapeuticdiscoveryanddevelopment
AT soniamayrapereztapia phagedisplaylibrariesforantibodytherapeuticdiscoveryanddevelopment
_version_ 1724729030231457792